Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Nathan T Glusenkamp , William J Oetgen , Brendan Mullen Added: 3 years ago
The past decade has seen impressive advances in cardiovascular (CV) care and reductions in patient mortality from CV disease (CVD). Between 1997 and 2007 (the year for which most recent final data are available), the death rate from CVD declined by 27.8 %. The actual number of CVD deaths per year declined by 14.2 % over this period. Meanwhile, the death rate for stroke fell by 44.8 % in the same… View more

Standards & Guidelines

Prevention & Chronic Conditions
Advocacy and Legislation for Cardiogenic Shock
Author(s): Kari Gorder , Steve Rudick , Timothy D Smith Added: 2 years ago

Heart Failure
Author(s): Larry A Allen , John S Rumsfeld Added: 3 years ago
Hospital readmissions contribute significant clinical and economic burden to patients and payers.1 Nearly 20 % of Medicare patients are readmitted to the hospital within 30 days of discharge, with heart failure listed as the most common reason for readmission.2 Based on a more than twofold variation in institutional readmission rates adjusted for patient clinical characteristics,3 preventable… View more

Standards & Guidelines

Digital Health
Author(s): Neal W White Jr Added: 3 years ago
Hospital to Home (H2H) is a national quality improvement initiative of the American College of Cardiology (ACC) and the Institute for Healthcare Improvement (IHI). It builds on the success of the ACC Door-to-Balloon Alliance for Quality and the IHI 100K Lives and 5 Million Lives campaigns. The goal of the H2H initiative is to reduce 30-day all-cause readmission rates for patients discharged with… View more

Anticoagulation

Standards & Guidelines
Author(s): Leslee J Shaw , C Noel Bairey Merz , Steven E Reis , et al Added: 3 years ago
Recent findings from landmark clinical trials, such as the Women's Health Initiative (WHI)1,2, have significantly altered current thinking about the role of postmenopausal hormone therapy (HT) in cardiovascular disease (CVD) prevention. HT was a therapy widely accepted by women and physicians, often used for CVD prevention purposes, based on observational epidemiologic data and plausible… View more

Prevention & Chronic Conditions

Demographic
Research Area(s) / Expertise:
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President-Elect of the American Society for Preventive Cardiology. She was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. Previously, she held the Sarah Ross Soter Chair in Women’s Cardiovascular Health and was the Section Director for Women’s Cardiovascular Health and Preventive Cardiology at The… View more
Roxana Mehran
Research Area(s) / Expertise: Job title: Professor of Medicine, Cardiology and Professor of Population Health Science and Policy
Roxana Mehran is Professor of Medicine, Cardiology and Professor of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai in New York. She is also Director of Interventional Cardiovascular Research and Clinical Trials at The Zena and Michael A Weiner Cardiovascular Institute at Mount Sinai Hospital where, over the past 5 years, she has led the development of a… View more
Diversity in Cardiovascular Disease: Are we Failing the General Population?
Author(s): Martha Gulati Added: 4 days ago
In this video series recorded at ACC 2024 in Atlanta, US, Prof Martha Gulati (Cedars-Sinai Smidt Heart Institute, Los Angeles, US) unveils pivotal data from four posters addressing the pressing issue of inequality in cardiology and healthcare. Gain a deeper understanding of personalised treatment approaches, recognise the importance of inclusivity in clinical trials and confront disparities in… View more

CV Disease in Special Populations
Author(s): Christopher R deFilippi , G Michael Felker Added: 3 years ago
Biomarkers have become central to the management of cardiovascular disease, and their potential clinical applications continue to grow. This article reviews galectin-3 (Gal-3), a novel biomarker of fibrosis and remodeling, and its clinical application in heart failure (HF). Case Studies Case Study One A 63-year-old African-American female presents to the emergency department with acute dyspnea… View more

Heart Failure

MI/ACS
Foreword

Article

Author(s): Matthew J Budoff Added: 3 years ago
We are at a considerable crossroads in medicine and cardiology. The Affordable Care Act may provide us with more coverage for needed preventive services and provide 35 million people with some form of healthcare coverage, but the overall ‘pie’ of healthcare dollars will be shrinking, in an attempt to forestall the failure of Medicare and the further debt spending of the US. A call for a balanced… View more

Imaging & Diagnostics